Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups
[...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable (
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2018-01, Vol.71 (1), p.108-108 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 108 |
|---|---|
| container_issue | 1 |
| container_start_page | 108 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 71 |
| creator | Magnuson, Elizabeth A. Bonaca, Marc P. Bhatt, Deepak L. Cohen, Marc Steg, Philippe Gabriel Storey, Robert F. Braunwald, Eugene Sabatine, Marc S. Cohen, David J. |
| description | [...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable ( |
| doi_str_mv | 10.1016/j.jacc.2017.10.079 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1989536425</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717415130</els_id><sourcerecordid>1985663897</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-93f6267364752545bc298d90e561b5a80cb123985fe9d67161cbab428273d733</originalsourceid><addsrcrecordid>eNpdkc1q3DAUhUVoaKZJXyCLIugmG0_0M5KskE0YkjYwoSEd6FLI8vVUxmNNJHvAb5NnyZNV06SbrgSHj4-rcxA6p2ROCZWX7by1zs0ZoSoHc6L0EZpRIcqCC60-oBlRXBSUaHWCPqXUEkJkSfVHdMI0zwLGZ2j_BLtuusLLkIbitmnADX4PPaSEQ4NXod8Ua4hbvPbObiJ0IWLf40c7eOiHhH_54Td-jD7HD1NwNtbedq8v931jYzaF_grf9Labkk-4mvDPsdrEMO7SGTpubJfg8_t7itZ3t-vl92L149v98mZVANNsKDRvJJOKy4USTCxE5Zgua01ASFoJWxJXUcZ1KRrQtVRUUlfZasFKpnitOD9FF2_aXQzPI6TBbH1y0HW2hzAmQ3WpRbYzkdGv_6FtGGO-_S8lpOSlVpn68k6N1RZqs4t-a-Nk_hWages3APKv9h6iSS5X5aD2MXdr6uANJeawn2nNYT9z2O-Q5f34H_HLjRc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1985663897</pqid></control><display><type>article</type><title>Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups</title><source>Elsevier ScienceDirect Journals Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Magnuson, Elizabeth A. ; Bonaca, Marc P. ; Bhatt, Deepak L. ; Cohen, Marc ; Steg, Philippe Gabriel ; Storey, Robert F. ; Braunwald, Eugene ; Sabatine, Marc S. ; Cohen, David J.</creator><creatorcontrib>Magnuson, Elizabeth A. ; Bonaca, Marc P. ; Bhatt, Deepak L. ; Cohen, Marc ; Steg, Philippe Gabriel ; Storey, Robert F. ; Braunwald, Eugene ; Sabatine, Marc S. ; Cohen, David J.</creatorcontrib><description>[...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable (<$70,000 per quality-adjusted life-year gained). Cost-effectiveness of long-term ticagrelor in patients with prior myocardial infarction: results from the PEGASUS-TIMI 54 trial, J Am Coll Cardiol, Vol. 70, 2017, 527-538 3 D.L. Bhatt, M.P. Bonaca, S. Bansilal, Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54, J Am Coll Cardiol, Vol. 67, 2016, 2732-2740 4 S. Bansilal, M. Bonaca, J.H. Cornel, Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in patients with prior MI and multivessel coronary disease: insights from the PEGASUS-TIMI 54 Trial, J Am Coll Cardiol, Vol. 67, Iss.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.10.079</identifier><identifier>PMID: 29301623</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Cardiovascular disease ; Cost analysis ; Disease prevention ; Health risk assessment ; Heart attacks ; Myocardial infarction ; Subgroups</subject><ispartof>Journal of the American College of Cardiology, 2018-01, Vol.71 (1), p.108-108</ispartof><rights>2018 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Jan 2, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109717415130$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29301623$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Magnuson, Elizabeth A.</creatorcontrib><creatorcontrib>Bonaca, Marc P.</creatorcontrib><creatorcontrib>Bhatt, Deepak L.</creatorcontrib><creatorcontrib>Cohen, Marc</creatorcontrib><creatorcontrib>Steg, Philippe Gabriel</creatorcontrib><creatorcontrib>Storey, Robert F.</creatorcontrib><creatorcontrib>Braunwald, Eugene</creatorcontrib><creatorcontrib>Sabatine, Marc S.</creatorcontrib><creatorcontrib>Cohen, David J.</creatorcontrib><title>Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>[...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable (<$70,000 per quality-adjusted life-year gained). Cost-effectiveness of long-term ticagrelor in patients with prior myocardial infarction: results from the PEGASUS-TIMI 54 trial, J Am Coll Cardiol, Vol. 70, 2017, 527-538 3 D.L. Bhatt, M.P. Bonaca, S. Bansilal, Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54, J Am Coll Cardiol, Vol. 67, 2016, 2732-2740 4 S. Bansilal, M. Bonaca, J.H. Cornel, Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in patients with prior MI and multivessel coronary disease: insights from the PEGASUS-TIMI 54 Trial, J Am Coll Cardiol, Vol. 67, Iss.</description><subject>Cardiovascular disease</subject><subject>Cost analysis</subject><subject>Disease prevention</subject><subject>Health risk assessment</subject><subject>Heart attacks</subject><subject>Myocardial infarction</subject><subject>Subgroups</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkc1q3DAUhUVoaKZJXyCLIugmG0_0M5KskE0YkjYwoSEd6FLI8vVUxmNNJHvAb5NnyZNV06SbrgSHj4-rcxA6p2ROCZWX7by1zs0ZoSoHc6L0EZpRIcqCC60-oBlRXBSUaHWCPqXUEkJkSfVHdMI0zwLGZ2j_BLtuusLLkIbitmnADX4PPaSEQ4NXod8Ua4hbvPbObiJ0IWLf40c7eOiHhH_54Td-jD7HD1NwNtbedq8v931jYzaF_grf9Labkk-4mvDPsdrEMO7SGTpubJfg8_t7itZ3t-vl92L149v98mZVANNsKDRvJJOKy4USTCxE5Zgua01ASFoJWxJXUcZ1KRrQtVRUUlfZasFKpnitOD9FF2_aXQzPI6TBbH1y0HW2hzAmQ3WpRbYzkdGv_6FtGGO-_S8lpOSlVpn68k6N1RZqs4t-a-Nk_hWages3APKv9h6iSS5X5aD2MXdr6uANJeawn2nNYT9z2O-Q5f34H_HLjRc</recordid><startdate>20180102</startdate><enddate>20180102</enddate><creator>Magnuson, Elizabeth A.</creator><creator>Bonaca, Marc P.</creator><creator>Bhatt, Deepak L.</creator><creator>Cohen, Marc</creator><creator>Steg, Philippe Gabriel</creator><creator>Storey, Robert F.</creator><creator>Braunwald, Eugene</creator><creator>Sabatine, Marc S.</creator><creator>Cohen, David J.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180102</creationdate><title>Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups</title><author>Magnuson, Elizabeth A. ; Bonaca, Marc P. ; Bhatt, Deepak L. ; Cohen, Marc ; Steg, Philippe Gabriel ; Storey, Robert F. ; Braunwald, Eugene ; Sabatine, Marc S. ; Cohen, David J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-93f6267364752545bc298d90e561b5a80cb123985fe9d67161cbab428273d733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Cardiovascular disease</topic><topic>Cost analysis</topic><topic>Disease prevention</topic><topic>Health risk assessment</topic><topic>Heart attacks</topic><topic>Myocardial infarction</topic><topic>Subgroups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Magnuson, Elizabeth A.</creatorcontrib><creatorcontrib>Bonaca, Marc P.</creatorcontrib><creatorcontrib>Bhatt, Deepak L.</creatorcontrib><creatorcontrib>Cohen, Marc</creatorcontrib><creatorcontrib>Steg, Philippe Gabriel</creatorcontrib><creatorcontrib>Storey, Robert F.</creatorcontrib><creatorcontrib>Braunwald, Eugene</creatorcontrib><creatorcontrib>Sabatine, Marc S.</creatorcontrib><creatorcontrib>Cohen, David J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Magnuson, Elizabeth A.</au><au>Bonaca, Marc P.</au><au>Bhatt, Deepak L.</au><au>Cohen, Marc</au><au>Steg, Philippe Gabriel</au><au>Storey, Robert F.</au><au>Braunwald, Eugene</au><au>Sabatine, Marc S.</au><au>Cohen, David J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2018-01-02</date><risdate>2018</risdate><volume>71</volume><issue>1</issue><spage>108</spage><epage>108</epage><pages>108-108</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>[...]all manifestations of cardiovascular disease are associated with high costs, and cost-effectiveness ratios for those other subgroups were quite reasonable (<$70,000 per quality-adjusted life-year gained). Cost-effectiveness of long-term ticagrelor in patients with prior myocardial infarction: results from the PEGASUS-TIMI 54 trial, J Am Coll Cardiol, Vol. 70, 2017, 527-538 3 D.L. Bhatt, M.P. Bonaca, S. Bansilal, Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54, J Am Coll Cardiol, Vol. 67, 2016, 2732-2740 4 S. Bansilal, M. Bonaca, J.H. Cornel, Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in patients with prior MI and multivessel coronary disease: insights from the PEGASUS-TIMI 54 Trial, J Am Coll Cardiol, Vol. 67, Iss.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29301623</pmid><doi>10.1016/j.jacc.2017.10.079</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2018-01, Vol.71 (1), p.108-108 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1989536425 |
| source | Elsevier ScienceDirect Journals Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Cardiovascular disease Cost analysis Disease prevention Health risk assessment Heart attacks Myocardial infarction Subgroups |
| title | Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T12%3A04%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply:%20Cost-Effectiveness%20of%20Long-Term%20Ticagrelor%20in%20Patients%20With%20Prior%20Myocardial%C2%A0Infarction:%20Analysis%20by%20Subgroups&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Magnuson,%20Elizabeth%20A.&rft.date=2018-01-02&rft.volume=71&rft.issue=1&rft.spage=108&rft.epage=108&rft.pages=108-108&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.10.079&rft_dat=%3Cproquest_pubme%3E1985663897%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1985663897&rft_id=info:pmid/29301623&rft_els_id=S0735109717415130&rfr_iscdi=true |